Document is current
Any future updates will be listed below
-
Authors
Day, Jessica
Kushlaf, Hani
Tarvin, Stacey
Cavagna, Lorenzo
Codullo, Veronica
Shinjo, Samuel Katsuyuki
Lyu, Xia
Knitza, Johannes
Hajji, Raouf
Blier, Peter R.
Tseng, Chih Wei
Appenzeller, Simone
Rider, Lisa G.
Christopher-Stine, Lisa
Gupta, Latika https://orcid.org/0000-0003-2753-2990
,
-
Funding
Funding for this research was provided by:
Sylvia and Charles Viertel Charitable Foundation (Clinical Investigator Award)
John T Reid Charitable Trusts Centenary Fellowship
RACP Australian Rheumatology Association & D.E.V Starr Research Establishment Fellowship
Royal Melbourne Hospital Victor Hurley Medical Research Grant in Aid
Intramural Research Program of the National Institute of Environmental Health Sciences, National Institutes of Health (ZIA ES101081)
- License Information
-
More Information
Article History
Accepted: 2 August 2024
First Online: 31 August 2024
Declarations
:
: Disclosures for Potential Conflicts of Interest: HK has received consultancy fees from Agenx, Sanofi, Alexion, AstraZeneca, UCB, Immunovant and Takeda. HK has research grants from the Muscular Dystrophy Association and Healey ALS Platform Trial. ST has served on the editorial board of the American Academy of Pediatrics, has received funding from the Childhood Arthritis Rheumatology Research Alliance and has served as site PI for trials with Roche, UCB, Pfizer and Abbvie. ST’s institution has received educational grants from the Rheumatology Research Foundation and Arthritis Foundation, LGR’s institution has received funding from the American College of Rheumatology. All remaining authors declare no potential conflicts of interest relating to this work.
